Dermatology Physician Assistant National Certifying Examination (PANCE) Practice

Contact dermatitis is primarily mediated by a Type IV hypersensitivity reaction, which is also known as delayed-type hypersensitivity. This immune response involves T-lymphocytes (T-cells) rather than antibodies. When a sensitizing agent, such as poison ivy or nickel, comes into contact with the skin, it is processed by antigen-presenting cells and presented to T-cells. This leads to a cascade of immune responses characterized by inflammation and tissue damage after subsequent exposures to the same allergen.

The delayed nature of this hypersensitivity reaction is why symptoms typically do not appear until 24 to 48 hours after re-exposure to the allergen. This distinguishes it from other types of hypersensitivity reactions, such as Type I, which is immediate and mediated by IgE antibodies, causing rapid allergic reactions. Type II hypersensitivity involves antibody-mediated destruction of cells, often seen in conditions like hemolytic anemia, while Type III hypersensitivity involves immune complex formation, leading to inflammation and damage in conditions like lupus or serum sickness.

Understanding the mechanics of Type IV hypersensitivity is crucial for diagnosing and managing contact dermatitis effectively, as it underscores the importance of avoiding known allergens and possibly employing topical corticosteroids to reduce inflammation during flare-ups.